Emergent Biosolutions Inc Share Price CINNOBER BOAT
Equities
0IGA
US29089Q1058
Pharmaceuticals
Sales 2024 * | 1.03B 86.21B | Sales 2025 * | 1.14B 94.96B | Capitalization | 344M 28.69B |
---|---|---|---|---|---|
Net income 2024 * | -156M -13.02B | Net income 2025 * | -110M -9.18B | EV / Sales 2024 * | 0.44 x |
Net Debt 2024 * | 111M 9.28B | Net Debt 2025 * | 336M 28.04B | EV / Sales 2025 * | 0.6 x |
P/E ratio 2024 * |
-2.6
x | P/E ratio 2025 * |
-3.12
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.39% |
Latest transcript on Emergent Biosolutions Inc
Managers | Title | Age | Since |
---|---|---|---|
Joseph Papa
CEO | Chief Executive Officer | 68 | 21/02 |
Richard Lindahl
DFI | Director of Finance/CFO | 70 | 26/18/26 |
Kelly Warfield
CTO | Chief Tech/Sci/R&D Officer | - | 17/23/17 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 01/22/01 |
Marvin White
BRD | Director/Board Member | 61 | 01/10/01 |
Louis Sullivan
BRD | Director/Board Member | 90 | 01/05/01 |
1st Jan change | Capi. | |
---|---|---|
+54.61% | 811B | |
+43.79% | 640B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+18.00% | 246B | |
+2.62% | 225B | |
+12.76% | 218B | |
+8.61% | 168B |